Your current location:HOME >opinions >China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial 正文
TIME:2024-04-30 07:37:14 Source: Internet compilationEdit:opinions
Contact Us HomeNewsHighlightACWF NewsSocietyWom
A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
United Methodists prepare for votes on lifting LGBTQ bans and other issues at General Conference2024-04-30 07:36
3 Body Problem: Lawyer sentenced to death for Lin Qi murder2024-04-30 07:12
Petrobras reports net profit of BRL 124.6 bi in 20232024-04-30 06:52
Japanese PM to US lawmakers: US does not have to confront global challenges alone2024-04-30 06:14
Chinese, PNG FMs hold in2024-04-30 06:04
New Zealand being considered as potential AUKUS Pillar Two partner2024-04-30 06:00
UN suspends aid movements at night in Gaza2024-04-30 05:49
DOC job cuts plan: Tourism, backcountry huts, flora and fauna at risk, groups say2024-04-30 05:39
Nvidia to buy Israeli AI company for estimated $700M2024-04-30 05:34
Climate activist Greta Thunberg detained twice at demonstration in The Hague2024-04-30 05:06
Program to boost cultural exchanges between China and France2024-04-30 07:31
How to make sure your leftovers are safe to eat2024-04-30 07:18
Department of Conservation proposes 130 job cuts2024-04-30 07:09
Finnish police say bullying was motive for school shooting2024-04-30 06:41
Sri Lanka expresses hope to join BRICS+2024-04-30 06:39
How electorate candidates funded their campaigns2024-04-30 06:37
Tens of thousands of Israelis rally in Tel Aviv demanding Gaza hostage deal2024-04-30 06:33
US Treasury Secretary explains her 'magic mushroom' experience in China2024-04-30 06:22
Finnish carrier suspends Estonia flights after GPS interference prevents 2 landings2024-04-30 06:10
Grief and anger in Moscow following concert attack2024-04-30 05:23